Effects of a 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Inhibitor, Fluvastatin, on Coronary Spasm After Withdrawal of Calcium-Channel BlockersHirofumi Yasue, Yoshihiko Saito, Kiyotaka Kugiyama et al.|Journal of the American College of Cardiology|2008Cited by 177
Coronary Vasomotor Response to Intracoronary Acetylcholine Injection, Clinical Features, and Long‐term Prognosis in 873 Consecutive Patients With Coronary Spasm: Analysis of a Single‐Center Study Over 20 YearsKoji Sato, Hisao Ogawa, Kenichi Tsujita et al.|Journal of the American Heart Association|2013Cited by 159
Microvascular Coronary Artery Spasm Presents Distinctive Clinical Features With Endothelial Dysfunction as Nonobstructive Coronary Artery DiseaseKeisuke Ohba, Hisao Ogawa, Masaaki Konishi et al.|Journal of the American Heart Association|2012Cited by 110
Coronary Microvascular Dysfunction and Diastolic Load Correlate With Cardiac Troponin T Release Measured by a Highly Sensitive Assay in Patients With Nonischemic Heart FailureSeiji Takashio, Hisao Ogawa, Kenichi Tsujita et al.|Journal of the American College of Cardiology|2013Cited by 89
Growth Differentiation Factor-15 Is a Useful Prognostic Marker in Patients With Heart Failure With Preserved Ejection FractionYasuhiro Izumiya, Hisao Ogawa, Seiji Takashio et al.|Canadian Journal of Cardiology|2013Cited by 77